Novartis (Singapore) Pte Ltd 20 Pasir Panjang Road #10-25/28 Mapletree Business City Singapore 117439 Phone: +65 6722 6010 Fax: +65 63234335

P4-ZYK-16/EVENTS/072017

19 August 2017Grand Copthorne Waterfront

MLCC 2017 Tea Break Symposium

This meeting is for healthcare professionals only. The event might expose contents which are off-label in the context of current approved status from Singapore HSA. Any clinical use based on those updates is with full responsibility and liability of respective healthcare professionals.

Welcome remarks Dr. Daniel TanSenior Consultant National Cancer Centre (Singapore)

Emerging gene mutations in NSCLC after EGFR and the role of targeted therapies: Focus on ALK, ROS1, BRAFLecture 1: Prof. Byoung Chul CHOAssociate Professor Yonsei Cancer Centre, Yonsei University College of Medicine (South Korea) Lecture 2: Prof. Tae Min KIM Associate Professor Seoul National University Hospital (South Korea)

Q & A

Programme10.00

10.35

P4-ZYK-16/EVENTS/072017

Novartis (Singapore) Pte Ltd 20 Pasir Panjang Road #10-25/28 Mapletree Business City Singapore 117439 Phone: +65 6722 6010 Fax: +65 63234335

P4-ZYK-16/EVENTS/072017This meeting is for healthcare professionals only. The event might expose contents which are off-label in the context of current approved status from Singapore HSA. Any clinical use based on those updates is with full responsibility and liability of respective healthcare professionals.

P4-ZYK-16/EVENTS/072017

19 August 2017Grand Copthorne Waterfront

MLCC 2017 Tea Break Symposium

Key Speakers

Prof. Byoung Chul Cho received his Doctor of Medicine and License for General Medicine from South Korea where he continued to complete his Masters in Medicine and PhD at Yonsei University College of Medicine.  Professor Cho's academic and research interests lies in cancer genomics of head and neck and thoracic oncology and resistance mechanisms of targeted therapies for these specific cancer types. In lung cancer research, he has led global clinical studies on oncogene driven lung cancers with focus on various gene mutations like EGFR, ALK, ROS1 and RET.

Currently, Prof. Cho serves as Associate Professor, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine.

PROF. TAE MIN KIM MD, PhD

Associate Professor, Department of Internal Medicine Seoul National University Hospital Seoul, South Korea

Prof. Tae Min Kim is currently an Associate Professor in the Department of Internal Medicine at the Seoul National University Hospital. He graduated from the Seoul National University College of Medicine and completed his MD, MSc and PhD at his alma mater. He is also an active member of several professional communities, especially those related to cancer in Korea.

Professor Kim’s clinical interests are in lung cancer and lymphoma management. In these fields, he was the main author of more than 25 publications and he has led more than 80 clinical trials as the principal investigator. His research results are published in well-established peer-reviewed journals such as the Journal of Clinical Oncology, Annals of Oncology, and American Journal of Pathology.

PROF. BYOUNG CHUL CHO MD, PhD

Associate ProfessorDivision of Medical OncologyYonsei University College of MedicineSeoul, South Korea